Skip to main content

Table 2 Frequency of common adverse events

From: Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy

Drug

Adverse Events

Frequency

SPAQ

Weakness

1.25%

 

Cough

1.25%

 

Rashes

0.84%

SP

Weakness

1.25%

 

Cough

1.25%

 

Rashes

0.84%

 

Anorexia

0.84%

 

Diarrhea

1.25%

AQ

Weakness

02.5%

 

Cough

0.42%

 

Rashes

0.42%

  1. Frequencies represented here were calculated across all study sites and represent those whose frequencies exceeded 0.